Combined PD-1, BRAF and MEK inhibition in BRAF(V600E) colorectal cancer: a phase 2 trial. Tian J, Chen JH, Chao SX, Pelka K, et al. Nat Med 2023;29:458-466.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tian J, Chen JH, Chao SX, Pelka K, et al. Combined PD-1, BRAF and MEK inhibition in BRAF(V600E) colorectal cancer: a phase 2 trial. Nat Med 2023;29:458-466.
PMID: 36702949